New Market Report Now Available: Turkey Pharmaceuticals & Healthcare Report Q4 2013
Turkey's pharmaceutical market has posted nominal growth in local currency terms and stemmed the decline in US dollar terms. However, imports continued their precipitous decline year-overyear, with local drugmakers picking up the slack. Continued fiscally-conservative policies by the AKP government have held back pharmaceutical spending by the SSI and kept its growth in check, even as the SSI struggles to overcome its structural deficit. Turkey stands to lose its status as a high-growth emerging market if it maintains its regressive...
View full press release